BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34510261)

  • 1. Imaging findings and treatment outcomes of a rare subtype of medication-related osteonecrosis of the jaw.
    Otsuru M; Soutome S; Hayashida S; Yanamoto S; Sasaki M; Takagi Y; Sumi M; Umeda M
    J Bone Miner Metab; 2022 Jan; 40(1):150-156. PubMed ID: 34510261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.
    Soutome S; Otsuru M; Hayashida S; Yanamoto S; Sasaki M; Takagi Y; Sumi M; Kojima Y; Sawada S; Iwai H; Umeda M; Saito T
    Support Care Cancer; 2021 Nov; 29(11):6361-6368. PubMed ID: 33884506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
    Sakamoto Y; Sawada S; Kojima Y
    Sci Rep; 2023 Aug; 13(1):12890. PubMed ID: 37558709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery.
    Soutome S; Yanamoto S; Sumi M; Hayashida S; Kojima Y; Sawada S; Rokutanda S; Iwai H; Saito T; Umeda M
    J Bone Miner Metab; 2021 Mar; 39(2):302-310. PubMed ID: 33047190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Segmentation Analysis of the Radiological Changes by Using ITK-SNAP: Risk Assessment of the Severity and Recurrence of Medication-related Osteonecrosis of the Jaw.
    Zhou YQ; Son GH; Shi YQ; Yu YJ; Li MY; Zhang Q; Zou DH; Zhang ZY; Yang C; Wang SY
    Int J Med Sci; 2021; 18(10):2209-2216. PubMed ID: 33859529
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative assessment of mandibular bone marrow using computed tomography texture analysis for detect stage 0 medication-related osteonecrosis of the jaw.
    Ito K; Muraoka H; Hirahara N; Sawada E; Hirohata S; Otsuka K; Okada S; Kaneda T
    Eur J Radiol; 2021 Dec; 145():110030. PubMed ID: 34798536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-related osteonecrosis of the lower jaw without osteolysis on computed tomography images.
    Kojima Y; Sawada S; Sakamoto Y
    J Bone Miner Metab; 2024 Jan; 42(1):27-36. PubMed ID: 38194089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with prognosis of patients with medication-related osteonecrosis of the jaw.
    Tadokoro Y; Hasegawa T; Takeda D; Murakami A; Yatagai N; Arimoro S; Iwata E; Saito I; Kusumoto J; Akashi M
    Head Neck; 2024 Feb; 46(2):282-290. PubMed ID: 37962011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Exacerbating Clinical Symptoms and CT Findings in Patients with Medication-Related Osteonecrosis of the Jaw Receiving Conservative Therapy: A Multicenter Retrospective Study of 53 Cases.
    Kojima Y; Soutome S; Otsuru M; Hayashida S; Sakamoto Y; Sawada S; Umeda M
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?
    Moreno Rabie C; García-Larraín S; Contreras Diez de Medina D; Cabello-Salazar I; Fontenele RC; Van den Wyngaert T; Jacobs R
    Dentomaxillofac Radiol; 2023 Nov; 52(8):20230304. PubMed ID: 37870051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.
    Wongratwanich P; Shimabukuro K; Konishi M; Nagasaki T; Ohtsuka M; Suei Y; Nakamoto T; Verdonschot RG; Kanesaki T; Sutthiprapaporn P; Kakimoto N
    Dentomaxillofac Radiol; 2021 Sep; 50(6):20200417. PubMed ID: 33411572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication-related osteonecrosis of the mandible: an unusual presentation and treatment.
    Rothweiler R; Voss PJ; Schmelzeisen R; Metzger MC
    Int J Oral Maxillofac Surg; 2021 Apr; 50(4):511-515. PubMed ID: 32847710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw.
    Kojima Y; Kawaoka Y; Sawada S; Hayashida S; Okuyama K; Yutori H; Kawakita A; Ishida S; Soutome S; Yanamoto S; Umeda M; Iwai H
    J Bone Miner Metab; 2019 Sep; 37(5):913-919. PubMed ID: 30830278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.
    Ogawa R; Ogura I
    Dentomaxillofac Radiol; 2021 Dec; 50(8):20200516. PubMed ID: 34019434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes and time to healing of medication-related osteonecrosis of the jaw based on image findings.
    Yasui T; Nagamine H; Tanaka K; Kimura M; Karube T; Kawana H; Onizawa K
    Dentomaxillofac Radiol; 2023 Jul; 52(5):20220352. PubMed ID: 37192041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate application and volumetric effects on MRONJ lesions.
    Lentzen MP; Buller J; Riekert M; Grandoch A; Kreppel M; Zöller JE; Zirk M
    J Craniomaxillofac Surg; 2021 Jun; 49(6):501-507. PubMed ID: 33853745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging features of medicine-related osteonecrosis of the jaws: comparison between panoramic radiography and computed tomography.
    Guo Y; Wang D; Wang Y; Peng X; Guo C
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):e69-76. PubMed ID: 27422431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.